Filed pursuant to Rule 433
Registration No.: 333-161696
October 8, 2009
Lexicon Pharmaceuticals, Inc.
$50,000,000
33,333,333 Shares of Common Stock
|
|
|
Issuer: |
|
Lexicon Pharmaceuticals, Inc. |
|
|
|
Symbol: |
|
LXRX |
|
|
|
Size: |
|
$50,000,000.00 |
|
|
|
Total Shares Offered: |
|
33,333,333 Shares of Common Stock |
|
|
|
Greenshoe Offered by Issuer: |
|
2,984,111 Shares of Common Stock |
|
|
|
Price to Public: |
|
$1.50 per share |
|
|
|
Trade Date: |
|
October 8, 2009 |
|
|
|
Closing Date: |
|
October 14, 2009 |
|
|
|
CUSIP No: |
|
528872104 |
|
|
|
Underwriters: |
|
Morgan Stanley & Co. Incorporated
|
|
|
Thomas Weisel Partners LLC |
Invus, L.P., the largest shareholder of Lexicon Pharmaceuticals, Inc., has agreed to purchase
13,439,257 of the 33,333,333 shares of Common Stock offered directly from Lexicon Pharmaceuticals,
Inc. at the per share price to the public set forth above.
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any
dealer participating in the offering will arrange to send you the prospectus if you request it by
calling toll-free 1-(866) 718-1649, or by emailing prospectus@morganstanley.com.